Role of dopamine D4 receptors in copulatory behavior: Studies with selective D4 agonists and antagonists in male rats.
Level 5 - mechanism / opinion, no new human data
Bench and animal research (rodent study)
PubMed 26287845 · doi:10.1016/j.pbb.2015.08.012
What was done
Sexually potent male rats were tested in copulation paradigms with receptive females after receiving selective dopamine D4 receptor agonists (PD-168,077 at 0.05-0.2 mg/kg s.c. or ABT-724 at 0.01-0.04 mg/kg s.c.) or a selective D4 receptor antagonist (L-745,870 at 1-5 mg/kg i.p.). Effects were compared with the non-selective dopamine agonist apomorphine and antagonist haloperidol, and antagonist pre-treatment was tested against both D4 agonists.
What was found
The abstract reports directional behavioral effects without exact numbers or statistical metrics. PD-168,077 decreased mount frequency and post-ejaculatory intervals. ABT-724 decreased mount frequency, ejaculation latency, post-ejaculatory intervals, and inter-intromission intervals. Both agonists increased ejaculation frequency and copulatory efficacy. L-745,870 dose-dependently increased intromission latency, ejaculation latency, mount frequency, and post-ejaculatory intervals while decreasing ejaculation frequency and copulatory efficacy. Pretreatment with L-745,870 (5 mg/kg) completely abolished the facilitatory effects of both agonists.
Why it matters
These findings delineate a specific role for dopamine D4 receptor subtypes in facilitating male sexual consummatory behavior, distinct from broader D2-family receptor mechanisms.
Limits
This is an animal study in male rats, limiting direct translation to human sexual function. The abstract does not report sample sizes, specific numerical values, effect sizes, or variance measures.
Cited by
- supports Dopamine can overcome the post-ejaculatory or post-coital refractory period.